Data / Medical devices / United States / Neomedico, LLC
Neomedico, LLC: FDA-registered device maker in Cheyenne, WY, United States, 17 PMA approvals
Neomedico, LLC is registered with the FDA (registration 3042708459) in Cheyenne, WY, United States. It lists 3 device types. The FDA files 17 PMA approvals under its listings, the newest dated October 19, 2017. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3042708459
- Address
- 1408 E 13th Street, Cheyenne, WY, United States, 82001
- Owner or operator
- Neomedico, Inc. (10094958)
- Roles
- Repackager or relabeler
- First device listed
- January 9, 2026
- Registered through
- 2026
- Brand names listed
- BELOTERO BALANCE, BELOTERO BALANCE WITH LIDOCAINE, DUROLANE, EUFLEXXA, HYALGAN, HYMOVIS, JUVEDERM ULTRA PLUS XC, JUVEDERM ULTRA XC and more
Devices it lists
| Device | Product code | Class | Role | Source |
|---|---|---|---|---|
| Acid, Hyaluronic, Intraarticular | MOZ | 3 | Repackager or relabeler | accessdata.fda.gov |
| Implant, Dermal, For Aesthetic Use | LMH | 3 | Repackager or relabeler | accessdata.fda.gov |
| Implant, Dermal, For Aesthetic Use In The Hands | PKY | 3 | Repackager or relabeler | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| October 19, 2017 | P170002 | RHA 2, RHA 3, RHA 4 | LMH | 55 | August 31, 2026 | accessdata.fda.gov |
| August 29, 2017 | P170007 | DUROLANE | MOZ | 15 | December 23, 2025 | accessdata.fda.gov |
| December 9, 2016 | P140029 | Restylane Refyne, Restylane Defyne | LMH | 51 | September 18, 2026 | accessdata.fda.gov |
| August 28, 2015 | P150010 | HYMOVIS | MOZ | 5 | April 9, 2025 | accessdata.fda.gov |
| February 25, 2014 | P090031 | MONOVISC | MOZ | 15 | August 8, 2023 | accessdata.fda.gov |
| October 22, 2013 | P110033 | JUVEDERM VOLUMA XC | LMH | 97 | August 28, 2026 | accessdata.fda.gov |
| November 14, 2011 | P090016 | BELOTERO BALANCE | LMH | 60 | May 3, 2026 | accessdata.fda.gov |
| December 22, 2006 | P050052 | RADIESSE INJECTABLE IMPLANT | LMH | 169 | June 26, 2026 | accessdata.fda.gov |
| December 22, 2006 | P050037 | RADIESSE 1.3CC AND 0.3CC | LMH | 147 | June 26, 2026 | accessdata.fda.gov |
| June 2, 2006 | P050047 | JUVEDERM 24HV, JUVEDERM 30 AND JUVEDERM 30HV GEL IMPLANTS | LMH | 101 | August 28, 2026 | accessdata.fda.gov |
| March 25, 2005 | P040024 | RESTYLANE INJECTABLE GEL | LMH | 132 | March 12, 2026 | accessdata.fda.gov |
| December 3, 2004 | P010029 | EUFLEXXA (1% SODIUM HYALURONATE) | MOZ | 40 | September 2, 2026 | accessdata.fda.gov |
| August 3, 2004 | P030050 | SCULPTRA AND SCULPTRA AESTHETIC | LMH | 54 | September 17, 2026 | accessdata.fda.gov |
| February 4, 2004 | P030019 | ORTHOVISC HIGH MOLECULAR WEIGHT HYALURONAN | MOZ | 23 | August 28, 2026 | accessdata.fda.gov |
| January 24, 2001 | P980044 | SUPARTZ FX | MOZ | 62 | September 4, 2026 | accessdata.fda.gov |
| August 8, 1997 | P940015 | SYNVISC ONE | MOZ | 51 | January 2, 2025 | accessdata.fda.gov |
| May 28, 1997 | P950027 | HYALGAN(R) | MOZ | 15 | June 28, 2024 | accessdata.fda.gov |
Compare with other makers
- All makers of Implant, Dermal, For Aesthetic Use
- All makers of Acid, Hyaluronic, Intraarticular
- All makers of Implant, Dermal, For Aesthetic Use In The Hands
Updated August 31, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.